NeuroOne Announces Participation in AES 2025 Annual Meeting and CNS Drug Delivery Summit

miércoles, 19 de noviembre de 2025, 8:39 am ET1 min de lectura
NMTC--

NeuroOne Medical Technologies Corporation will participate in the American Epilepsy Society 2025 Annual Meeting and the CNS Drug Delivery Summit. The AES Annual Meeting brings together professionals dedicated to better outcomes for people with epilepsy, while the CNS Drug Delivery Summit features industry experts tackling unique challenges in brain drug delivery. NeuroOne develops minimally invasive solutions for neurological disorders, including epilepsy, Parkinson's disease, and chronic pain.

NeuroOne Announces Participation in AES 2025 Annual Meeting and CNS Drug Delivery Summit

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios